Robeco Institutional Asset Management B.V. Purchases 263,871 Shares of Agilent Technologies, Inc. $A

Robeco Institutional Asset Management B.V. increased its position in Agilent Technologies, Inc. (NYSE:A) by 89.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 558,144 shares of the medical research company’s stock after purchasing an additional 263,871 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Agilent Technologies were worth $96,174,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. 55 North Private Wealth LLC boosted its holdings in shares of Agilent Technologies by 4.9% during the 3rd quarter. 55 North Private Wealth LLC now owns 1,658 shares of the medical research company’s stock valued at $286,000 after buying an additional 78 shares in the last quarter. Investment Research Partners LLC grew its position in shares of Agilent Technologies by 1.8% in the 3rd quarter. Investment Research Partners LLC now owns 3,646 shares of the medical research company’s stock worth $628,000 after buying an additional 63 shares during the period. Maia Wealth LLC purchased a new stake in shares of Agilent Technologies in the 3rd quarter worth about $212,000. Abel Hall LLC bought a new position in shares of Agilent Technologies in the 3rd quarter worth about $240,000. Finally, Jackson Square Capital LLC bought a new position in shares of Agilent Technologies in the 3rd quarter worth about $3,363,000.

Insiders Place Their Bets

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Agilent Technologies Trading Up 2.8%

Agilent Technologies stock opened at $177.93 on Thursday. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The business’s fifty day simple moving average is $160.50 and its two-hundred day simple moving average is $138.97. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $178.21. The company has a market capitalization of $50.16 billion, a price-to-earnings ratio of 35.03, a price-to-earnings-growth ratio of 2.63 and a beta of 1.21.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The company’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be paid a dividend of $0.2550 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, October 6th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.

Analyst Ratings Changes

A has been the subject of a number of recent research reports. Bank of America lifted their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective on the stock. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, October 17th. JPMorgan Chase & Co. raised their target price on shares of Agilent Technologies from $180.00 to $190.00 and gave the company an “overweight” rating in a research note on Thursday, August 27th. Finally, UBS Group assumed coverage on shares of Agilent Technologies in a report on Wednesday, September 9th. They set a “neutral” rating and a $165.00 target price for the company. Fifteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $173.65.

Agilent Technologies Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.